Therapeutic Approach

Archive: June, 2010

Ritter Pharmaceuticals, Inc. Receives FDA IND Approval For Lactose Intolerance Treatment

Ritter Pharmaceuticals, Inc. Receives FDA IND Approval For Lactose Intolerance Treatment LOS ANGELES- June 7, 2010- Ritter Pharmaceuticals, Inc. (Ritter), a pharmaceutical company with a focus on digestive diseases, announced that the United States Food and Drug Administration (FDA) has approved the Company┬┤s Investigational New Drug (IND) application for RP-G28, a novel therapeutic product for […]

Leave Your Comments »

Featuring Recent Posts WordPress Widget development by YD